Press release
-
Business Wire1 week ago
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
Novel treatment for PSVT developed with Milestone Pharmaceuticals CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–Aptar Group, Inc. (NYSE: ATR), a global leader in…
Read More » -
Business Wire1 week ago
United Security Bancshares Declares Quarterly Cash Dividend
FRESNO, Calif.–(BUSINESS WIRE)–On December 16, 2025, the Board of Directors of United Security Bancshares (the “Company”) (NASDAQ: UBFO), the parent…
Read More » -
Business Wire1 week ago
Morningstar and PitchBook Bring Trusted Investing Intelligence to Apps in ChatGPT
Morningstar and PitchBook’s Model Context Protocol (MCP) app integrations are now live, enabling licensed users to access proprietary public and…
Read More » -
Business Wire1 week ago
Granite REIT Declares Distribution for December 2025
TORONTO–(BUSINESS WIRE)–Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has…
Read More » -
Clywedog Therapeutics Announces Activation of All Centers and Patient Dosing in Multicenter, International Phase 1b Clinical Study of Balomenib in Type 2 Diabetes
DOVER, Del., Dec. 17, 2025 /PRNewswire/ — Clywedog Therapeutics, Inc., a clinical-stage biotechnology company advancing novel therapies for metabolic diseases,…
Read More » -
Brasswater Acquires Mont Tremblant Retail Village, One of Canada’s Premier Four-Season Destinations
MONTREAL, Dec. 17, 2025 /PRNewswire/ – Brasswater, a leading private real estate investment and development firm, announced today that it…
Read More » -
Press Release
OnePay and Greenshades Partner to Bring Financial Wellness to Millions of Frontline Workers
Greenshades to embed direct access to OnePay’s financial wellness tools in its platform NEW YORK, Dec. 17, 2025 /PRNewswire/ —…
Read More » -
Press Release
Equifax Secures 27 New Patents in the Second Half of 2025
20 Patents Support the Organization’s Approach to Responsible AI, Designed to Accelerate Product Innovation that Help to Create New Financial…
Read More » -
Eilean Therapeutics Advances ZE74-0282, a Highly Selective Inhibitor of Mutated JAK2 V617F, into First-in-Human Clinical Development
DOVER, Del., Dec. 17, 2025 /PRNewswire/ — Eilean Therapeutics announced the advancement of ZE74-0282 into first-in-human clinical development. ZE74-0282 is…
Read More » -
Press Release
Jazz Pharmaceuticals to Participate in Upcoming Investor Events
DUBLIN, Dec. 17, 2025 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the…
Read More »